Peter Thiel joins board of antibody therapy developer AbCellera

This post was originally published on this site
https://i-invdn-com.akamaized.net/trkd-images/LYNXMPEGAI1GT_L.jpg

Thiel, who has backed several startups as they went public, is an existing investor in AbCellera. He joins the startup’s board a couple of months after Reuters reported that it had hired investment banks for a U.S. initial public offering, which could come this year.

AbCellera has been working with Eli Lilly and Co (N:LLY) to develop a treatment for the novel coronavirus.

Thiel is known for his early investments in Facebook (O:FB) and co-founding electronic payment service provider Paypal Inc (O:PYPL). In September, he took data analytics firm Palantir Technologies Inc (N:PLTR) public through a direct-listing.

Add Comment